Atlas Trials

Feasibility of Risk-Adapted Therapy in Young Adult Acute Lymphoblastic Leukemia: a Multicenter Trial

Clinical trial NCT00222027 · COMPLETED

Trial details

NCT number
NCT00222027
Sponsor
University Hospital, Toulouse
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Lymphoblastic Leukemia
Start date
2003-11-01
Primary completion
2008-10-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.